Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Obesity | Research

The integrative panel of fatty acid desaturase-2 (FADS2) rs174583 gene polymorphism and dietary indices (DQI-I and HEI) affects cardiovascular risk factors among obese individuals

Authors: Mahsa Mahmoudinezhad, Sheida Khosravaniardakani, Leila Saljoughi Badelou, Ehsan Fayyazishishavan, Houman Kahroba, Mahdieh Abbasalizad Farhangi

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

Recent studies have shown that dietary intakes and gene variants have a critical role in the obesity related comorbidities. This study aimed to evaluate the effects of the interactions between Fatty acid desaturase 2 (FADS2) gene rs174583 polymorphism and two dietary indices on cardiometabolic risk factors.

Methods

This cross-sectional study was carried out on 347 obese adults aged 20-50 years old in Tabriz, Iran. Healthy eating index (HEI) and Diet quality index-international (DQI-I) were evaluated by a validated semi-quantitative 147-item Food frequency questionnaire (FFQ). Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to determine FADS2 gene variants. Multivariate analysis of covariance (MANCOVA) was used to identify gene-diet interactions on metabolic parameters.

Results

Waist circumference (WC) and serum triglyceride (TG) levels were significantly higher among carriers of TT genotype of FADS2 gene (P < 0.05). In addition, the interactions between FADS2 gene rs174583 polymorphism and DQI-I had significant effects on weight (P interaction = 0.01), fat mass (P interaction = 0.04), fat free mass (P interaction = 0.03), and Body mass index (BMI) (P interaction = 0.02); the highest level of these parameters belonged to TT carriers. Similarly, the interactions between FADS2 gene variants and HEI had significant effects on insulin (P interaction < 0.001), Homeostasis model assessment of insulin resistance (HOMA-IR) (P interaction < 0.001), Quantitative insulin check index (QUICKI) (P interaction = 0.001), and alpha Melanocyte stimulating hormone (α-MSH) (P interaction = 0.03).

Conclusion

In this study, for the first time, we reported the effects of gene-diet interactions on metabolic traits. Compliance with dietary indices (DQI-I and HEI) ameliorated the adverse effects of gene variants on metabolic risk factors, especially in heterogeneous genotypes. Further prospective cohort studies are needed to confirm these results.
Appendix
Available only for authorised users
Literature
1.
2.
Tang D, Bu T, Feng Q, Liu Y, Dong X. Differences in overweight and obesity between the north and south of China. Am J Health Behav. 2020;44(6):780–93.PubMedCrossRef
3.
Rahmani A, Sayehmiri K, Asadollahi K, Sarokhani D, Islami F, Sarokhani M. Investigation of the prevalence of obesity in Iran: a systematic review and meta-analysis study. Acta Medica Iranica. 2015;53(10):596–607.PubMed
4.
Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17.PubMedCrossRef
5.
Schroeder K, Kubik MY, Sirard JR, Lee J, Fulkerson JA. Sleep is inversely associated with sedentary time among youth with obesity. Am J Health Behav. 2020;44(6):756–64.PubMedPubMedCentralCrossRef
6.
Valerio A, Nisoli E, Rossi AP, Pellegrini M, Todesco T, El Ghoch M. Obesity and higher risk for severe complications of Covid-19: what to do when the two pandemics meet. J Popul Ther Clin Pharmacol. 2020;27(SP1):e31–e6.PubMedCrossRef
7.
Crovesy L, Rosado EL. Interaction between genes involved in energy intake regulation and diet in obesity. Nutrition (Burbank, Los Angeles County, Calif). 2019;67-68:110547–52.PubMedCrossRef
8.
Ulaganathan V, Kandiah M, Shariff ZM. A case–control study on the association of abdominal obesity and hypercholesterolemia with the risk of colorectal cancer. J Carcinogenesis. 2018;17:4.CrossRef
9.
Nasiri A. Parental care challenges in childhood obesity management: a qualitative study. Evid Based Care. 2022;11(4):7–15.
10.
Aghajani R, Nemati N, Hojjati Zidashti Z, Bagherpour T. Effect of aerobic program in the morning and afternoon on Obestatin and the body composition of overweight and obese women. J Chem Health Risks. 2020;10(2):117–25.
11.
Kamolthip R, Fung XC, Lin C-Y, Latner JD, O'Brien KS. Relationships among physical activity, health-related quality of life, and weight stigma in children in Hong Kong. Am J Health Behav. 2021;45(5):828–42.PubMedCrossRef
12.
Gasmi A, Noor S, Piscopo S, Menzel A. Lifestyle genetics-based reports in the treatment of obesity. Arch Razi Institute. 2021;76(4):707.
13.
de Toro-Martín J, Arsenault BJ, Després JP, Vohl MC. Precision nutrition: a review of personalized nutritional approaches for the prevention and management of metabolicsSyndrome. Nutrients. 2017;9(8):1–28.
14.
Abdullah MM, Vazquez-Vidal I, Baer DJ, House JD, Jones PJ, Desmarchelier C. Common genetic variations involved in the inter-individual variability of circulating cholesterol concentrations in response to diets: a narrative review of recent evidence. Nutrients. 2021;13(2):695.PubMedPubMedCentralCrossRef
15.
Huang MC, Chang WT, Chang HY, Chung HF, Chen FP, Huang YF, et al. FADS gene polymorphisms, fatty acid desaturase activities, and HDL-C in type 2 diabetes. Int J Environ Res Public Health. 2017;14(6):572–83.PubMedPubMedCentralCrossRef
16.
Atanasovska B, Kumar V, Fu J, Wijmenga C, Hofker MH. GWAS as a driver of gene discovery in cardiometabolic diseases. Trends Endocrinol Metab. 2015;26(12):722–32.PubMedCrossRef
17.
Gol S, Pena RN, Rothschild MF, Tor M, Estany J. A polymorphism in the fatty acid desaturase-2 gene is associated with the arachidonic acid metabolism in pigs. Sci Rep. 2018;8(1):14336–45.PubMedPubMedCentralCrossRef
18.
He Z, Zhang R, Jiang F, Zhang H, Zhao A, Xu B, et al. FADS1-FADS2 genetic polymorphisms are associated with fatty acid metabolism through changes in DNA methylation and gene expression. Clin Epigenetics. 2018;10(1):113–26.PubMedPubMedCentralCrossRef
19.
Bláhová Z, Harvey TN, Pšenička M, Mráz J. Assessment of fatty acid desaturase (Fads2) structure-function properties in fish in the context of environmental adaptations and as a target for genetic engineering. Biomolecules. 2020;10(2):1–13.CrossRef
20.
Naghibi D, Mohammadzadeh S, Azami-Aghdash S. Barriers to evidence-based practice in health system: a systematic review. Evid Based Care. 2021;11(2):74–82.
21.
Brown KM, Sharma S, Baker E, Hawkins W, Merwe MVD, Puppa MJ. Delta-6-desaturase (FADS2) inhibition and omega-3 fatty acids in skeletal muscle protein turnover. Biochem Biophys Rep. 2019;18:100622–9.PubMedPubMedCentral
22.
Guerra ZC, Moore JR, Londoño T, Castro Y. Associations of acculturation and gender with obesity and physical activity among Latinos. Am J Health Behav. 2022;46(3):324–36.PubMedCrossRef
23.
Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015;7:52–67.PubMedPubMedCentralCrossRef
24.
Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metab Clin Exp. 2010;59(7):993–1000.PubMedCrossRef
25.
Shetty SS, Devi H, Sharmila K, Rai S. Association of FADS2 rs174575 gene polymorphism and insulin resistance in type 2 diabetes mellitus. Afr Health Sci. 2020;20(4):1770–6.PubMedPubMedCentralCrossRef
26.
Kytikova OY, Novgorodtseva TP, Antonyuk M, Gvozdenko T. Associations of delta fatty acid desaturase gene polymorphisms with lipid metabolism disorders. Russian Open Med J. 2021;10(4):403.CrossRef
27.
Shetty SS, Kumari NS. Fatty acid desaturase 2 (FADS 2) rs174575 (C/G) polymorphism, circulating lipid levels and susceptibility to type-2 diabetes mellitus. Sci Rep. 2021;11(1):1–8.CrossRef
28.
Margină D, Ungurianu A, Purdel C, Nițulescu GM, Tsoukalas D, Sarandi E, et al. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Food Chem Toxicol. 2020;143:111558.PubMedPubMedCentralCrossRef
29.
Mazoochian L, Sadeghi H, Pourfarzam M. The effect of FADS2 gene rs174583 polymorphism on desaturase activities, fatty acid profile, insulin resistance, biochemical indices, and incidence of type 2 diabetes. J Res Med Sci. 2018;23:47–54.PubMedPubMedCentralCrossRef
30.
Pavlos S, Nikiforou C. Medicinal plants against obesity: a met-analysis of literature. J Complement Med Res. 2022;12(4):244.CrossRef
31.
Jontony N, Hill EB, Taylor CA, Boucher LC, O'Brien V, Weiss R, et al. Diet quality, carotenoid status, and body composition in NCAA division I athletes. Am J Health Behav. 2020;44(4):432–43.PubMedPubMedCentralCrossRef
32.
Anvigh B, Abedi V, Heydari S, Karamati D, Babajafari S, Najafi A, et al. Healthy eating index-2015 and bone mineral density among adult Iranian women. Arch Osteoporos. 2020;15(1):1–11.
33.
Hu EA, Steffen LM, Coresh J, Appel LJ, Rebholz CM. Adherence to the healthy eating index–2015 and other dietary patterns may reduce risk of cardiovascular disease, cardiovascular mortality, and all-cause mortality. J Nutr. 2020;150(2):312–21.PubMedCrossRef
34.
Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport. 2000;71(sup2):114–20.PubMedCrossRef
35.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.PubMedCrossRef
36.
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.PubMedCrossRef
37.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.PubMedCrossRef
38.
Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes. 2000;24(1):38–48.CrossRef
39.
Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.PubMedCrossRef
40.
Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran lipid and glucose study. Am J Epidemiol. 2010;20(2):150–8.CrossRef
41.
Ghaffarpour M, Rad AH, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods, vol. 7. Tehran: Nashre Olume Keshavarzy; 1999. p. 213.
42.
Kim S, Haines PS, Siega-Riz AM, Popkin BM. The diet quality index-international (DQI-I) provides an effective tool for cross-national comparison of diet quality as illustrated by China and the United States. J Nutr. 2003;133(11):3476–84.PubMedCrossRef
43.
Smith SMK, Pannucci TRE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the healthy eating index: HEI-2015. J Acad Nutr Diet. 2018;118(9):1591–602.CrossRef
44.
Malerba G, Schaeffe L, Xumerle L, Klopp N, Trabetti E, Biscuola M, et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids. 2008;43(4):289–99.PubMedCrossRef
45.
Park S, Kim DS, S. K. Carrying minor allele of FADS1 and haplotype of FADS1 and FADS2 increased the risk of metabolic syndrome and moderate but not low fat diets lowered the risk in two Korean cohorts. Eur J Nutr. 2019;58(2):831–42.PubMedCrossRef
46.
Sone Y, Kido T, Tomomi A, Sonoda M, Ichi I, Kodama S, et al. Genetic variants of the fatty acid desaturase gene cluster are associated with plasma LDL cholesterol levels in Japanese males. J Nutr Sci Vitaminol. 2013;59(4):325–35.PubMedCrossRef
47.
AbuMweis S, Panchal S, Jones P. Triacylglycerol-lowering effect of docosahexaenoic acid is not influenced by single-nucleotide polymorphisms involved in lipid metabolism in humans. Lipids. 2018;53(9):897–908.PubMedCrossRef
48.
Nakayama K, Bayasgalan T, Tazoe F, Yanagisawa Y, Gotoh T, Yamanaka K, et al. A single nucleotide polymorphism in the FADS1/FADS2 gene is associated with plasma lipid profiles in two genetically similar Asian ethnic groups with distinctive differences in lifestyle. Hum Genet. 2010;127(6):685–90.PubMedCrossRef
49.
Chen Y, Estampador AC, Keller M, Poveda A, Dalla-Riva J, Johansson I, et al. The combined effects of FADS gene variation and dietary fats in obesity-related traits in a population from the far north of Sweden: the GLACIER study. Int J Obes. 2019;43(4):808–20.CrossRef
50.
Warensjö E, Rosell M, Hellenius ML, Vessb B, De Faire U, Risérus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis. 2009;8(1):37–44.PubMedPubMedCentralCrossRef
51.
Kim OY, Lim HH, Yang LI, Chae JS, Lee JH. Fatty acid desaturase (FADS) gene polymorphisms and insulin resistance in association with serum phospholipid polyunsaturated fatty acid composition in healthy Korean men: cross-sectional study. Nutr Metab. 2011;8(1):24–35.CrossRef
Metadata
Title
The integrative panel of fatty acid desaturase-2 (FADS2) rs174583 gene polymorphism and dietary indices (DQI-I and HEI) affects cardiovascular risk factors among obese individuals
Authors
Mahsa Mahmoudinezhad
Sheida Khosravaniardakani
Leila Saljoughi Badelou
Ehsan Fayyazishishavan
Houman Kahroba
Mahdieh Abbasalizad Farhangi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01289-3

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue

Research

Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study

Research

Autoimmune thyroid status in subclinical thyroid disorders in patients attending a tertiary care center in Nepal: a hospital-based cross-sectional study

Research

Correlation between serum uric acid and body fat distribution in patients with MAFLD

Study Protocol

Stratified support pattern-based internet-assisted self-management therapy for diabetes mellitus -mild cognitive impairment: a randomized controlled trial protocol

Research

Association of Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and metabolically unhealthy overweight/obesity phenotypes among Iranian women: a cross sectional study

Research article

Multimorbidity at time of death among persons with type 2 diabetes: a population-based study in Ontario, Canada
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits